NCT01318317 2026-05-05Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin LymphomaCity of Hope Medical CenterPhase 1/2 Active not recruiting8 enrolled 13 charts